Clinical Trials Directory

Trials / Completed

CompletedNCT03837431

Cutaneous Leishmaniasis Diagnostic Study

Diagnosis of Cutaneous Leishmaniasis Using the CL-Detect Rapid Test in Ethiopia

Status
Completed
Phase
Study type
Observational
Enrollment
351 (actual)
Sponsor
Institute of Tropical Medicine, Belgium · Academic / Other
Sex
All
Age
2 Years
Healthy volunteers
Not accepted

Summary

The performance of the CL Detect Rapid test will be tested in individuals with suspected cutaneous leishmaniasis in Ethiopia using both skin slit and dental broach samples against a combined reference of microscopy and PCR. Alternative sampling methods will also be evaluated.

Detailed description

Cutaneous Leishmaniasis is common in Ethiopia and mainly affects the poor living in rural areas. Diagnosis of CL routinely uses invasive skin slits which are examined with microscopy, requiring trained staff and an equipped lab. A new rapid diagnostic test for CL which may be used in the field has been developed and validated in several countries where other Leishmania species are present. Less invasive tape sampling has also become available. Whether this new RDT and alternative sampling methods can be used in Ethiopia is unclear. The performance of the CL detect Rapid Test against a combined reference (microscopy and PCR) and alternative sample collection methods will be tested in CL suspected individuals in North-West Ethiopia in a cross-sectional study.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSkin slitSkin slit microscopy, RDT and PCR
DIAGNOSTIC_TESTDental broachDental broach RDT and PCR
DIAGNOSTIC_TESTTape discTape disc PCR

Timeline

Start date
2019-02-13
Primary completion
2022-08-12
Completion
2023-01-31
First posted
2019-02-12
Last updated
2023-03-01

Locations

1 site across 1 country: Ethiopia

Source: ClinicalTrials.gov record NCT03837431. Inclusion in this directory is not an endorsement.